BCAR3 promotes head and neck cancer growth and is associated with poor prognosis.

Zhang, Ze; Wang, Yafei; Wang, Yun; Wang, Chunli; Shuai, Yanjie; Luo, Jingtao; Liu, Ruoyan

Zhang, Ze; Wang, Yafei; Wang, Yun; Wang, Chunli; Shuai, Yanjie; Luo, Jingtao; Liu, Ruoyan.

Afiliação

Zhang Z; Department of Maxillofacial and Otorhinolaryngology Oncology, and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Wang Y; Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Wang Y; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Wang C; Department of Maxillofacial and Otorhinolaryngology Oncology, and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.
Shuai Y; Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, 300060, China.
Luo J; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Liu R; Department of Maxillofacial and Otorhinolaryngology Oncology, and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.

Cell Death Discov ; 7(1): 316, 2021 Oct 27.

Article em En | MEDLINE | ID: mdl-34707118

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google